Back

Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation

1 April 2025 (08:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Poster session 3: clinical management of arrhythmias Clinical EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jelena Simic

University Clinical Center of Serbia, Belgrade (Serbia)

139 More presentations in this session

Presentation thumbnail
The relationship between left atrial electroanatomical voltage mapping and CMR-based fibrosis for enhanced preplanning in atrial fibrillation ablation
Doctor Z. Dadon (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Cardiac sympathetic denervation for different cardiovascular indications - the experience of two referral centers
Doctor A. Zienciuk-Krajka (Gdansk, PL)
Abstract
Presentation thumbnail
Risk of left atrial thrombus in patients undergoing catheter ablation for atrial fibrillation and atrial flutter
Assistant Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Clustering analysis of left atrial smax patterns: predicting atrial fibrillation termination and associations with key clinical factors
Mr J. Huh (Seoul, KR)
Abstract Slides
Presentation thumbnail
Efficacy of semaglutide in reducing atrial fibrillation recurrence post-catheter ablation: propensity score-matched analysis
Professor G. Ciconte (San Donato Milanese, IT)
Abstract

Access the full session

Session thumbnail
Poster session 3: clinical management of arrhythmias

The Event

Event poster

EHRA 2025

1 April 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Quality indicators for atrial fibrillation management in daily practice: why and how?
thumbnail
Congress Presentation
Development of a systematic referral model to primary care health interventions for patients with atrial fibrillation. a delphi study.
thumbnail
Congress Presentation
The 2024 ESC Guidelines for the Management of Atrial Fibrillation serve physicians well but leave a few questions unanswered: a social media-based poll of 433 European and Asian physicians

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources